[P3–036]: MEDI1814, A HIGH‐AFFINITY ANTIBODY DIRECTED TO THE C‐TERMINUS OF AβX‐42, ABROGATES SYNAPTIC PLASTICITY DISRUPTION CAUSED BY SYNTHETIC OR AD BRAIN‐DERIVED Aβ SOLUBLE ASSEMBLIES IN VIVO. (1st July 2017)